CN1280855A - 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 - Google Patents
含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 Download PDFInfo
- Publication number
- CN1280855A CN1280855A CN99109881A CN99109881A CN1280855A CN 1280855 A CN1280855 A CN 1280855A CN 99109881 A CN99109881 A CN 99109881A CN 99109881 A CN99109881 A CN 99109881A CN 1280855 A CN1280855 A CN 1280855A
- Authority
- CN
- China
- Prior art keywords
- compositions
- algae
- liquid
- protein polyose
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/946—Microorganisms using algae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
第一天(n=10) | 第三天(n=10) | 第六天(n=7) | |
高剂量组 | 120±10.62(<0.01) | 89.3±3.59(<0.01) | 163.7±22.1(<0.01) |
中剂量组 | 70.67.74(<0.3) | 78.2±13.3(<0.05) | 109.3±8.03(<0.02) |
低剂量组 | 86.1±9.79(<0.05) | 56.7±4.34(<0.3) | 89.0±9.76(>0.5) |
照射对照组 | 57.2±6.02 | 47.0±3.82 | 85.6±4.5 |
空白对照组 | 354.4±25.2 | 277.1±28.12 | 313.3±24054 |
浓度(mg/ml)细胞株 | 5 | 1.67 | 0.56 | 0.185 | 0.062 | IC50(mg/ml) |
P-388 | 90.7 | 72.1 | 31.4 | 5.8 | 1.2 | 1.03 |
Hl-60 | 95.7 | 63.8 | 25.5 | 17.0 | 0.0 | 1.22 |
U-937 | 87.5 | 66.1 | 35.7 | 37.5 | 3.6 | 0.93 |
MKN-28 | 76.2 | 55.4 | 24.8 | 20.8 | 14.9 | 1.29 |
SGC-7901 | 48.3 | 6.2 | 2.1 | 3.4 | 0.0 | |
A-431 | 0.0 | 0.0 | 0.0 | 1.8 | 4.6 | |
SPC-A4 | 41.2 | 23.5 | 26.5 | 9.8 | 0.0 | |
5 | 3.3 | 2.2 | 1.48 | 0.99 | ||
A-549 | 92.4 | 86.4 | 50.0 | 30.3 | 54.5 | 2.0 |
NCI-H23 | 30.9 | 10.3 | 0.0 | 4.4 | 0.0 | |
DMS-114 | 75.0 | 63.5 | 46.2 | 36.5 | 19.2 | 2.36 |
Hep-G2 | 85.9 | 87.5 | 75.0 | 39.8 | 23.4 | 1.61 |
K562 | 85.1 | 73.1 | 41.8 | 29.9 | 19.4 | 2.18 |
MCF-7 | 0.0 | 6.3 | 20.8 | 1.7 | 0.0 | |
HCT-116 | 86.1 | 65.7 | 44.4 | 30.6 | 24.1 | 2.15 |
藻蛋白多糖提取物浓度(mg/ml) | 5.0 | 2.5 | 1.2 | 0.6 | 0.3 |
抑制率(%) | 100 | 100 | 100 | 67.9 | 65.0 |
藻蛋白多糖提取物浓度(mg/ml) | 1.5 | 0.75 | 0.4 | 0.2 | 0.1 |
抑制率(%) | 94.1 | 72.5 | 62.7 | 62.7 | 47.1 |
藻蛋白多糖提取物浓度(mg/ml) | 1.2 | 0.6 | 0.3 | 0.15 | 0.07 |
抑制率(%) | 89 | 80.6 | 67.7 | 54.1 | 37.7 |
组别 | 细胞数/50mm2(平均数) | 未成熟细胞占比例(平均数) | 细胞分裂相 |
空白对照组 | 140 | 40 | 有 |
照射对照组 | 31 | 4 | 无 |
低剂量组 | 72 | 30 | 有 |
高剂量组 | 74 | 35 | 有 |
阳性对照组 | 45 | 35 | 有 |
组别 | 空白对照组 | 照射对照组 | 低剂量组 | 中剂量组 | 高剂量组 | 阳性对照组 |
DNA含量μg/ml | 49.04 | 2.01 | 2.71 | 8.94 | 6.34 | 3.56 |
27.03 | 2.94 | 8.42 | 10.00 | 4.82 | 2.38 | |
27.92 | 1.58 | 7.19 | 7.79 | 6.14 | 4.79 | |
27.19 | 4.42 | 3.70 | 6.34 | |||
平均值 | 32.79 | 2.18 | 5.68 | 8.91 | 5.25 | 4.27 |
P | <0.05 | <0.01 | <0.01 | <0.01 |
组别 | 平均γ-球蛋白相对百分含量(±SD) |
空白对照 | 10.07±3.57 |
空白对照 | 12.84±6.75 |
照射对照 | 6.19±4.96 |
照射给药 | 13.32±6.73 |
组别 | T淋巴细胞百分率 | P值 |
空白对照 | 28.0±2.55 | |
阳性对照 | 25.6±2.51 | |
高剂量 | 39.8±7.40 | <0.01 |
低剂量 | 33.2±6.30 | <0.05 |
Claims (49)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99109881A CN1098707C (zh) | 1999-07-19 | 1999-07-19 | 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 |
EP00945521A EP1197218B1 (en) | 1999-07-19 | 2000-07-19 | Algae protein polysaccharide extraction and use thereof |
ES00945521T ES2365319T3 (es) | 1999-07-19 | 2000-07-19 | Extracción de polisacaridos de proteinas de algas y uso de los mismos. |
US10/031,520 US6893642B1 (en) | 1999-07-19 | 2000-07-19 | Algae protein polysaccharide extraction and use thereof |
JP2001510468A JP4023717B2 (ja) | 1999-07-19 | 2000-07-19 | スピルリナのプロテオグリカン抽出物およびその使用方法 |
AU59613/00A AU5961300A (en) | 1999-07-19 | 2000-07-19 | Algae protein polysaccharide extraction and use thereof |
DE60045894T DE60045894D1 (de) | 1999-07-19 | 2000-07-19 | Extraktion von polysaccharide aus algenprotein und verwendung davon |
AT00945521T ATE506956T1 (de) | 1999-07-19 | 2000-07-19 | Extraktion von polysaccharide aus algenprotein und verwendung davon |
PCT/CN2000/000205 WO2001005414A1 (fr) | 1999-07-19 | 2000-07-19 | Extrait de polysaccharide d'une proteine d'algue et son utilisation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99109881A CN1098707C (zh) | 1999-07-19 | 1999-07-19 | 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1280855A true CN1280855A (zh) | 2001-01-24 |
CN1098707C CN1098707C (zh) | 2003-01-15 |
Family
ID=5274217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99109881A Expired - Fee Related CN1098707C (zh) | 1999-07-19 | 1999-07-19 | 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6893642B1 (zh) |
EP (1) | EP1197218B1 (zh) |
JP (1) | JP4023717B2 (zh) |
CN (1) | CN1098707C (zh) |
AT (1) | ATE506956T1 (zh) |
AU (1) | AU5961300A (zh) |
DE (1) | DE60045894D1 (zh) |
ES (1) | ES2365319T3 (zh) |
WO (1) | WO2001005414A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102020705B (zh) * | 2009-09-15 | 2012-08-15 | 长江大学 | 一种螺旋藻分离蛋白的制备方法 |
CN102834021A (zh) * | 2010-04-06 | 2012-12-19 | 赫里开发公司 | 从盐水藻类选择性提取蛋白质 |
CN104351752A (zh) * | 2014-09-19 | 2015-02-18 | 南京农业大学 | 一种来源于食用菌\海藻的多糖蛋白复配功能胶囊产品的生产方法 |
CN108472323A (zh) * | 2016-01-20 | 2018-08-31 | 齐清 | 包含藻蛋白多糖提取物的组合物及其用途 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080124286A1 (en) * | 2006-11-28 | 2008-05-29 | Lisson Jerold B | Algae supplement and treatment method |
US20080124318A1 (en) * | 2006-11-28 | 2008-05-29 | Jerold Lisson | Algae supplement and treatment method |
TWI414362B (zh) | 2011-05-18 | 2013-11-11 | Ind Tech Res Inst | 萃取裝置 |
JP7166578B2 (ja) * | 2017-07-18 | 2022-11-08 | 国立大学法人 和歌山大学 | 抗ウイルス剤 |
JP7131937B2 (ja) * | 2018-03-28 | 2022-09-06 | 森永乳業株式会社 | スピルリナ含有緑色飲料及びその製造方法 |
WO2023135950A1 (ja) * | 2022-01-11 | 2023-07-20 | 一丸ファルコス株式会社 | プロテオグリカンを含む免疫応答調節剤 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58128322A (ja) * | 1982-01-27 | 1983-07-30 | Kurorera Kogyo Kk | 制癌剤 |
JPS6466126A (en) * | 1987-09-07 | 1989-03-13 | Lion Corp | Antitumor agent |
JPH06263649A (ja) * | 1993-01-13 | 1994-09-20 | Maruha Corp | 免疫賦活剤 |
JP3020387B2 (ja) * | 1993-07-27 | 2000-03-15 | 日石三菱株式会社 | 抗ウイルス物質 |
JP3403496B2 (ja) * | 1993-09-24 | 2003-05-06 | 株式会社ヤクルト本社 | 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤 |
CN1036067C (zh) * | 1994-08-24 | 1997-10-08 | 沈阳医药工业研究所 | 从螺旋藻中提取蛋白质和多糖的方法 |
CN1064969C (zh) | 1994-08-31 | 2001-04-25 | 张媛贞 | 钝顶节旋藻藻蓝蛋白及其应用 |
CN1130028A (zh) | 1995-02-27 | 1996-09-04 | 陈志龙 | 藻蓝蛋白的制备方法 |
JPH09176022A (ja) * | 1995-12-26 | 1997-07-08 | Dainippon Ink & Chem Inc | 腫瘍転移抑制剤 |
JPH09176002A (ja) * | 1995-12-27 | 1997-07-08 | Kureha Chem Ind Co Ltd | Hsp27ファミリーに属するタンパク質のジンゲロール含有合成抑制剤 |
CN1119946C (zh) * | 1997-11-27 | 2003-09-03 | 中国科学院水生生物研究所 | 螺旋藻营养成分的提取方法 |
-
1999
- 1999-07-19 CN CN99109881A patent/CN1098707C/zh not_active Expired - Fee Related
-
2000
- 2000-07-19 AT AT00945521T patent/ATE506956T1/de not_active IP Right Cessation
- 2000-07-19 DE DE60045894T patent/DE60045894D1/de not_active Expired - Lifetime
- 2000-07-19 ES ES00945521T patent/ES2365319T3/es not_active Expired - Lifetime
- 2000-07-19 AU AU59613/00A patent/AU5961300A/en not_active Abandoned
- 2000-07-19 JP JP2001510468A patent/JP4023717B2/ja not_active Expired - Lifetime
- 2000-07-19 US US10/031,520 patent/US6893642B1/en not_active Expired - Lifetime
- 2000-07-19 WO PCT/CN2000/000205 patent/WO2001005414A1/zh active Application Filing
- 2000-07-19 EP EP00945521A patent/EP1197218B1/en not_active Expired - Lifetime
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102020705B (zh) * | 2009-09-15 | 2012-08-15 | 长江大学 | 一种螺旋藻分离蛋白的制备方法 |
CN102834021A (zh) * | 2010-04-06 | 2012-12-19 | 赫里开发公司 | 从盐水藻类选择性提取蛋白质 |
CN104351752A (zh) * | 2014-09-19 | 2015-02-18 | 南京农业大学 | 一种来源于食用菌\海藻的多糖蛋白复配功能胶囊产品的生产方法 |
CN104351752B (zh) * | 2014-09-19 | 2017-07-18 | 南京农业大学 | 一种来源于食用菌\海藻的多糖蛋白复配功能胶囊产品的生产方法 |
CN108472323A (zh) * | 2016-01-20 | 2018-08-31 | 齐清 | 包含藻蛋白多糖提取物的组合物及其用途 |
CN108472323B (zh) * | 2016-01-20 | 2019-11-08 | 齐清 | 包含藻蛋白多糖提取物的组合物及其用途 |
CN110507676A (zh) * | 2016-01-20 | 2019-11-29 | 齐清 | 包含藻蛋白多糖提取物的组合物及其用途 |
CN110507675A (zh) * | 2016-01-20 | 2019-11-29 | 齐清 | 包含藻蛋白多糖提取物的组合物及其用途 |
CN110538202A (zh) * | 2016-01-20 | 2019-12-06 | 齐清 | 包含藻蛋白多糖提取物的组合物及其用途 |
US10729743B2 (en) | 2016-01-20 | 2020-08-04 | Qing Qi | Composition comprising an algal proteoglycan extract and use thereof |
US11389503B2 (en) | 2016-01-20 | 2022-07-19 | Qing Qi | Composition comprising an algal proteoglycan extract and use thereof |
US11464826B2 (en) | 2016-01-20 | 2022-10-11 | Qing Qi | Composition comprising an algal proteoglycan extract and use thereof |
US11648288B2 (en) | 2016-01-20 | 2023-05-16 | Qing Qi | Composition comprising an algal proteoglycan extract and use thereof |
Also Published As
Publication number | Publication date |
---|---|
ES2365319T3 (es) | 2011-09-29 |
US6893642B1 (en) | 2005-05-17 |
DE60045894D1 (de) | 2011-06-09 |
CN1098707C (zh) | 2003-01-15 |
EP1197218A4 (en) | 2004-06-09 |
JP2003504410A (ja) | 2003-02-04 |
AU5961300A (en) | 2001-02-05 |
EP1197218B1 (en) | 2011-04-27 |
ATE506956T1 (de) | 2011-05-15 |
JP4023717B2 (ja) | 2007-12-19 |
WO2001005414A8 (fr) | 2001-06-28 |
EP1197218A1 (en) | 2002-04-17 |
WO2001005414A1 (fr) | 2001-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1098707C (zh) | 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 | |
CN1092204C (zh) | 20(S)-人参皂甙Rg3的半合成方法及其药物用途 | |
CN1857615A (zh) | 一种治疗肝炎和胆囊炎的药物及其制备方法和应用 | |
CN1224392C (zh) | 薯蓣皂苷元在制备治疗胃癌药物中的应用 | |
CN1568960A (zh) | 高纯度绿原酸制剂 | |
CN101032532A (zh) | 一种含有从桑黄中提取的活性物质的药物组合物、制备方法及其在制备药物中的应用 | |
CN1172677C (zh) | 黄芪甲苷在制备药物组合物中的应用 | |
CN1895244A (zh) | 一种预防及治疗癌症的药物组合物 | |
CN1788722A (zh) | 预防和治疗痴呆的组合物 | |
CN1127950C (zh) | 抗风湿剂 | |
CN1148944A (zh) | 一种保健粉剂 | |
CN1698676A (zh) | 荔枝果皮提取物及其制备方法和用途 | |
CN1268323C (zh) | 一种圣地红景天软胶囊制剂及其制备方法 | |
CN1102066C (zh) | 一种治疗艾滋病和肿瘤的药剂及其制备方法 | |
CN1810284A (zh) | 一种云南重楼提取物及制备方法、药用用途和药物组合物 | |
CN1418633A (zh) | 一种以20(s)-原人参二醇为有效成分的抗癌辅助药物及应用 | |
CN100339090C (zh) | 新的石榴叶提取物及其医药用途 | |
CN1281593C (zh) | 苯并异硒唑衍生物的免疫调节和生物治疗作用 | |
CN1261452C (zh) | 用鳖或/和龟的血清提取的糖缀合物chb和制备工艺及其在制药中的应用 | |
CN1742783A (zh) | 一种扶正益气天然药物制剂及其制备方法 | |
CN100340186C (zh) | 姬松茸水溶性多糖及其制备工艺和用途 | |
CN1186026C (zh) | 羟乙葛根素在制备治疗缺血性脑血管病新药中的应用 | |
CN1278732C (zh) | 一种用于癌症辅助治疗的中药复方制剂及制备方法 | |
CN1660836A (zh) | 脱氢卡维丁类化合物及其在医药中的应用 | |
CN1957944A (zh) | 红豆杉多糖在制药中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of registration: 20070425 Pledge (preservation): Pledge |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20070516 Pledge (preservation): Pledge |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20080911 Pledge (preservation): Pledge registration |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20080911 Pledge (preservation): Pledge |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20090710 Pledge (preservation): Pledge registration |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20090710 Pledge (preservation): Pledge |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Beijing Ke Rui biological medicine technology Co., Ltd. Assignor: Qi Qing Contract fulfillment period: 2006.12.16 to 2011.12.15 Contract record no.: 2009110000291 Denomination of invention: Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose Granted publication date: 20030115 License type: Exclusive license Record date: 20091112 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2006.12.16 TO 2011.12.15; CHANGE OF CONTRACT Name of requester: BEIJING KERY BIO-PHARMA LTD. Effective date: 20091112 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Beijing Ke Rui biological medicine technology Co., Ltd. Assignor: Qi Qing Contract record no.: 2009110000291 Date of cancellation: 20110516 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20110601 Granted publication date: 20030115 Pledgee: Bank of Communications Ltd Beijing Zhongguancun Park sub branch Pledgor: Qi Qing Registration number: 2009110000578 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose Effective date of registration: 20110602 Granted publication date: 20030115 Pledgee: Bank of Communications Ltd Beijing Zhongguancun Park sub branch Pledgor: Qi Qing Registration number: 2011990000204 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20130107 Granted publication date: 20030115 Pledgee: Bank of Communications Ltd Beijing Zhongguancun Park sub branch Pledgor: Qi Qing Registration number: 2011990000204 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20010124 Assignee: Beijing Ke Ke Biotechnology Co., Ltd. Assignor: Qi Qing Contract record no.: 2013110000051 Denomination of invention: Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose Granted publication date: 20030115 License type: Exclusive License Record date: 20131011 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Beijing Ke Ke Biotechnology Co., Ltd. Assignor: Qi Qing Contract record no.: 2013110000051 Date of cancellation: 20161206 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030115 Termination date: 20170719 |